Point32Health challenges Aduhelm, threatens coverage for 1.1M members
(By Nick Moran for Becker’s Hospital Review) Point32Health may not cover Biogen’s new Alzheimer’s treatment, Aduhelm, for its commercial members unless
Read More
Alzheimer’s/Dementia
A crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it?
(By Megan Molteni for STAT) For families and physicians grappling with the historic approval this month of the controversial Alzheimer’s
Read MoreQ&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read More‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
(By Elizabeth Cooney for STAT) Their phones are ringing off the hook and their email inboxes are filling up with
Read MoreFDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) The question of what would happen when
Read MoreThe FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial
(By Scott Hensley, Jon Hamilton, and Laurel Wamsley for NPR) The Food and Drug Administration approved the drug aducanumab to
Read MoreQuestions to ask after you receive the diagnosis of Alzheimer’s
Hearing the diagnosis of Alzheimer’s disease is difficult to absorb, but once the diagnosis sinks in, it is a good
Read MoreFDA Weighs Approval of a Lucrative Alzheimer’s Drug but Benefits Are Iffy
(By Harris Meyer for Kaiser Health News) The Food and Drug Administration’s decision next week whether to approve the first
Read MoreAiding Her Dying Husband, a Geriatrician Learns the Emotional and Physical Toll of Caregiving
(By Judith Graham for Kaiser Health News) The loss of a husband. The death of a sister. Taking in an
Read MoreAlzheimer’s disease has four distinct subtypes
Scientists have found that Alzheimer’s disease has four distinct subtypes based on brain scan images. The researchers’ findings could help
Read More